
REM sleep behavior disorder (RBD) is one of the most important factors predicting Parkinson's disease. Symptoms constitute vivid dreams typically characterized by ominous contents and associated muscular activity. Specific signs include the preservation of muscle tone during REM sleep as detected in polysomnography, and behavior associated with dreaming as demonstrated by video monitoring. Injury risk is increased during the attacks. Melatonin or clonazepam can be used as therapy. The disorder belongs to the entity of synucleinopathies.
Diagnosis, Differential, Polysomnography, Humans, Parkinson Disease, REM Sleep Behavior Disorder, GABA Modulators, Clonazepam, Melatonin
Diagnosis, Differential, Polysomnography, Humans, Parkinson Disease, REM Sleep Behavior Disorder, GABA Modulators, Clonazepam, Melatonin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
